Oxford Biodynamics had an equally rough five trading days, with 70% of its market value wiped out after announcing it was seeking new funding.
The company outlined plans for senior staff to take a quarter of their pay in newly issued shares and revealed a review into further funding options, alongside potential asset sales or a spin-off of its US division. The stock ended the week at 1.17p.